BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12888613)

  • 1. Insulin effect on lung diffusion: NO pathway.
    Boulbou M; Gourgoulianis K; Molyvdas PA
    Am J Respir Crit Care Med; 2003 Aug; 168(3):398; author reply 398-9. PubMed ID: 12888613
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect.
    Guazzi M; Brambilla R; De Vita S; Guazzi MD
    Am J Respir Crit Care Med; 2002 Oct; 166(7):978-82. PubMed ID: 12359657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply to commentary on: confusion in reporting pulmonary diffusion capacity for nitric oxide and the alveolar-capillary membrane conductance for nitric oxide.
    Agostoni P; Magini A; Apostolo A
    Eur J Prev Cardiol; 2015 Mar; 22(3):314-6. PubMed ID: 24659025
    [No Abstract]   [Full Text] [Related]  

  • 4. Confusion in reporting pulmonary diffusing capacity for nitric oxide and the alveolar-capillary membrane conductance for nitric oxide.
    Zavorsky GS; Borland C
    Eur J Prev Cardiol; 2015 Mar; 22(3):312-3. PubMed ID: 24676716
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced lung diffusion capacity in type 2 diabetes is independent of heart failure.
    Klein OL; Jones M; Lee J; Collard HR; Smith LJ
    Diabetes Res Clin Pract; 2012 Jun; 96(3):e73-5. PubMed ID: 22436730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet dysfunction associated with insulin therapy in patients with type 2 diabetes: please do not throw the baby out with the bathwater!
    Scheen AJ; Legrand D
    J Am Coll Cardiol; 2007 Feb; 49(5):628; author reply 628-9. PubMed ID: 17276192
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus.
    Mori H; Okubo M; Okamura M; Yamane K; Kado S; Egusa G; Hiramoto T; Hara H; Yamakido M
    Intern Med; 1992 Feb; 31(2):189-93. PubMed ID: 1600265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small amount of inhaled nitric oxide does not increase lung diffusing capacity.
    Zavorsky GS; Murias JM
    Eur Respir J; 2006 Jun; 27(6):1251-7. PubMed ID: 16540495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of tiotropium on the pulmonary diffusing capacity.
    Gonlugur U
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is insulin treatment a first-line defense against Type 2 diabetes?
    Richard J; Lingvay I
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):483-5. PubMed ID: 20397820
    [No Abstract]   [Full Text] [Related]  

  • 11. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
    Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
    Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
    [No Abstract]   [Full Text] [Related]  

  • 12. Sildenafil improves the alveolar-capillary function in heart failure patients.
    Bussotti M; Montorsi P; Amato M; Magini A; Baldassarre D; Tantardini F; Veglia F; Agostoni P
    Int J Cardiol; 2008 May; 126(1):68-72. PubMed ID: 17490765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symposium of oral hypoglycemic agents on receptor and postreceptor actin of insulin.
    Diabetes Care; 1984; 7 Suppl 1():1-129. PubMed ID: 6376022
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of iNO in the modulation of pulmonary vascular resistance.
    Bin-Nun A; Schreiber MD
    J Perinatol; 2008 Dec; 28 Suppl 3():S84-92. PubMed ID: 19057617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and heart failure: is insulin therapy the answer?
    Levy WC; Hirsch IB
    J Am Coll Cardiol; 2003 Sep; 42(6):1051-3. PubMed ID: 13678929
    [No Abstract]   [Full Text] [Related]  

  • 16. [Defective nitric oxide homeostasis. Common underlying mechanism between insulin resistance, sympathetic overactivity and cardiovascular morbidity and mortality].
    Schwab M; Bloch J; Duplain H; Sartori C; Scherrer U
    Medicina (B Aires); 2008; 68(3):243-50. PubMed ID: 18689158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in diffusion capacity of the lungs during treatment of patients with dust-induced diseases of the broncho-pulmonary system].
    Gladkova EV
    Sov Med; 1973 Jul; 36(7):94-8. PubMed ID: 4776717
    [No Abstract]   [Full Text] [Related]  

  • 18. Diffusing capacity in pulmonary fibrosis, sarcoidosis and bronchogenic carcinoma.
    Lopez-Majano V
    Respiration; 1972; 29(1):17-23. PubMed ID: 5018994
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes and the female reproductive system.
    Nandi A; Poretsky L
    Endocrinol Metab Clin North Am; 2013 Dec; 42(4):915-46. PubMed ID: 24286956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones in heart failure: slippery when wet.
    Khush KK
    J Card Fail; 2008 Aug; 14(6):453-5. PubMed ID: 18672191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.